COV (NYSE)
| Price: | $52.74 |
| Change: | 0.61 |
| Volume: | 2,276,701 |
Minimum 20 minute delay
2/1/2012 5:09:25 PM
Covidien: WHO: …1/30/2012 7:00:51 AM
Covidien Revascularization Device Approved for Interventional Management of Stroke Trial
Physicians request Solitaire™ FR device for randomized, open-label multi-center study MANSFIELD, Mass.--(BUSINESS WIRE)--Jan. 30, 2012-- Covidien (NYSE:COV), a leading global provider of healthcare products, today announced that the Solitaire™ FR Revascularization Device has been approved for investigational use in the Interventional Management of Stroke (IMS III) trial. The Solitaire FR device was approved by the IMS III Executive Committee in the thrombectomy arm of the trial and was included in a recently approved amendment submitted to the …1/26/2012 6:01:00 AM
Covidien Reports First-Quarter Results
View PDF Net sales up 5%; Medical Devices sales up 6% First-quarter diluted GAAP earnings per share from continuing operations were $1.02; excluding specified items, adjusted diluted earnings per share from continuing operations were $1.13, up 19% Fiscal 2012 sales guidance updated DUBLIN…1/24/2012 4:30:09 PM
Clinical Data for DURABILITY II Study Presented at ISET 2012
MIAMI--(BUSINESS WIRE)--Jan. 24, 2012-- Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that one-year results on the use of its EverFlex™ stent for superficial femoral artery stenting were presented here during the International Symposium on Endovascular Therapy…
A Partner in Health
Collaborating with physicians and other healthcare professionals, focusing on research and development and maintaining clinical leadership add up to innovative medical solutions that make a difference.
Conscientious Collaboration
Ensuring ethical interactions with healthcare professionals is vital to the global healthcare environment. Covidien’s Conscientious Collaboration platform is our commitment to open communications about the need to ensure compliant interactions with our customers and partners.
One Covidien
One look. One Covidien. Experience the new unified look of Covidien. Easy-to-use labeling. New outside packaging with the same quality products inside. First-class service and support.
Visit Us
